Paris Longevity Dinner #2
On the eve of the Longevity Investors Conference in Gstaad, Switzerland, we're hosting a private dinner in Paris, France for investors, founders and scientists working in the field of longevity.
Whether you're based in Paris, stopping by en route to Gstaad or are willing to re-route your trajectory to attend, we are extremely grateful to have you with us!
Register your interest above and we'll send confirmation details as soon as we have a final guest list.
In case you missed our first dinner in Paris, check out the summary & photos here.
Unit Ventures is a micro-fund investing in early stage deep tech and frontier science. The investment team is comprised of General Partner, Dr. Rand Hindi, and Managing Partner, Kyle O'Brien.
Our longevity investments include: Tomorrow Biostasis, Glycanage, Deciduous Therapeutics, BE Therapeutics and Chipiron.